NATURAL HEALTH TRENDS CORP
For the period ended Dec 31, 2025. Filed Feb 20, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 20, 2026
NHTC$0.74-0.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In Thousands)
| Year Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net income (loss) | $(882) | $572 |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Depreciation and amortization | 109 | 131 |
| Net accretion of marketable securities | (375) | (441) |
| Share-based compensation | 132 | 145 |
| Noncash lease expense | 1,140 | 1,087 |
| Deferred income taxes | 102 | 17 |
| Changes in assets and liabilities: | ||
| Inventories | 1,274 | 1,000 |
| Other current assets | 1,224 | (113) |
| Other assets | (640) | (421) |
| Accounts payable | (341) | (94) |
| Income taxes payable | (4,902) | (3,862) |
| Accrued commissions | (111) | (19) |
| Other accrued expenses | (7) | 271 |
| Deferred revenue | (854) | 245 |
| Amounts held in eWallets | (445) | (672) |
| Operating lease liabilities | (1,142) | (1,151) |
| Other current liabilities | (279) | (62) |
| Net cash used in operating activities | (5,997) | (3,367) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchases of property and equipment | (68) | (57) |
| Purchases of marketable securities | (50,742) | (70,431) |
| Proceeds from maturities of marketable securities | 58,958 | 40,413 |
| Net cash provided by (used in) investing activities | 8,148 | (30,075) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Dividends paid | (9,210) | (9,213) |
| Net cash used in financing activities | (9,210) | (9,213) |
| Effect of exchange rates on cash, cash equivalents and restricted cash | 312 | 5 |
| Net decrease in cash, cash equivalents and restricted cash | (6,747) | (42,650) |
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period | 13,567 | 56,217 |
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period | $6,820 | $13,567 |
| SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES: | ||
| Right-of-use assets obtained in exchange for operating lease liabilities | $487 | $124 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.